Impact of the interaction of R207910 with rifampin on the treatment of tuberculosis studied in the mouse model.
about
TMC207: the first compound of a new class of potent anti-tuberculosis drugsNew agents for the treatment of drug-resistant Mycobacterium tuberculosisBedaquiline for the treatment of multidrug-resistant tuberculosis: great promise or disappointment?Antituberculosis therapy for 2012 and beyondA Review of the Evidence for Using Bedaquiline (TMC207) to Treat Multi-Drug Resistant TuberculosisIn vitro interactions between new antitubercular drug candidates SQ109 and TMC207.The chemical biology of new drugs in the development for tuberculosis.A new in vivo model to test anti-tuberculosis drugs using fluorescence imaging.Bactericidal potencies of new regimens are not predictive of their sterilizing potencies in a murine model of tuberculosis.Activities of TMC207, rifampin, and pyrazinamide against Mycobacterium tuberculosis infection in guinea pigs.Sterilizing activity of novel TMC207- and PA-824-containing regimens in a murine model of tuberculosisCurrent development and future prospects in chemotherapy of tuberculosisSafety, tolerability, and pharmacokinetic interactions of the antituberculous agent TMC207 (bedaquiline) with efavirenz in healthy volunteers: AIDS Clinical Trials Group Study A5267.ATP synthase and the actions of inhibitors utilized to study its roles in human health, disease, and other scientific areas.Model-based estimates of the effects of efavirenz on bedaquiline pharmacokinetics and suggested dose adjustments for patients coinfected with HIV and tuberculosis.New drugs against tuberculosis: problems, progress, and evaluation of agents in clinical development.Update in tuberculosis 2008.Emerging drugs for the treatment of tuberculosis.New treatment options for multidrug-resistant tuberculosis.TMC207 becomes bedaquiline, a new anti-TB drug.Bedaquiline - The first ATP synthase inhibitor against multi drug resistant tuberculosis.Bedaquiline for the treatment of drug-resistant tuberculosis.Management of drug resistantTB in patients with HIV co-infection.Treatment of multidrug-resistant and extensively drug-resistant tuberculosis: current status and future prospects.Bedaquiline: A novel drug to combat multiple drug-resistant tuberculosis.
P2860
Q24632091-E87CD84F-8C6A-4B80-A292-926CF39BDE24Q26751463-2941E327-9C21-4F05-A945-CDC056CFE3F5Q26824413-6003C8DC-516A-4BA5-A8D5-8AD793F8C531Q26829101-76FF20B7-68FC-4D9C-9923-E9DE0A7D205DQ33939074-BEB46EFF-897B-411A-98F1-66C820493CEEQ33962793-C1EA241C-53B0-4AA3-ABA7-ECAFD4E634B1Q34054325-A7B90818-7858-44FA-97A2-33D722F9D1C7Q34283632-3DF3B06C-AFD6-4D51-BCDC-1936F6A0502EQ34290060-1D36C1CB-4A63-43FB-B812-DCEF2878D175Q34483596-01F0B50B-4220-465D-9977-4D8E2DC60AC5Q35598474-BE154D11-ED15-4E8C-BC59-6ADE8ABBFA4AQ35705874-E2A975D1-06F3-416F-B54D-BB45548EB412Q35827839-E9FAF59A-C019-4AF0-969B-28CCAE1B6479Q36995302-606F12FC-AE5F-4A6B-97AE-863EA787EE11Q37026667-FCA7E0BE-81A8-4FC9-A0E0-2CD722AC2A31Q37346929-092DE0F9-E7AF-4BD2-9FA2-A21678BFE140Q37398528-B64CB20A-FFC3-43E6-A2FD-470B758F9E7BQ37792105-BF596402-6E5A-48BB-9BFC-48EAC72CEEEDQ38024041-3DA83DEF-59E0-494C-8785-76B54F09A0C5Q38135901-CD1D91E6-D571-4C59-A115-E95EF6FB38B0Q38190535-E3BE5D0D-2AB8-4379-8375-641A1F6288ADQ38386950-D699BD8B-799B-4636-9A19-A99C1B39181FQ38610637-6643E70C-E18D-4436-853C-F97B832A9128Q39967041-8502F25A-F302-44EF-A433-FB8284FEE9F0Q41929194-89EFF02C-D2A8-447F-B284-8ABDF4B8EC8D
P2860
Impact of the interaction of R207910 with rifampin on the treatment of tuberculosis studied in the mouse model.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Impact of the interaction of R ...... is studied in the mouse model.
@en
type
label
Impact of the interaction of R ...... is studied in the mouse model.
@en
prefLabel
Impact of the interaction of R ...... is studied in the mouse model.
@en
P2093
P2860
P356
P1476
Impact of the interaction of R ...... is studied in the mouse model.
@en
P2093
Joke Van Den Berg
Koen Andries
Nacer Lounis
Tom Gevers
P2860
P304
P356
10.1128/AAC.00566-08
P407
P577
2008-07-21T00:00:00Z